Ibio Helps US Government Control Ebola Outbreak Ibio

New Post Public Reply Private Reply Replies (1) Message Board
fitzkarz

Ibio Helps US Government Control Ebola Outbreak
Ibio Helps US Government Control Ebola Outbreak
Ibio was up 15% during extended trading on the announcement that it will provide the US government with its iBioLaunch technology to ramp up Ebola drug production

Page 1 of 2

Published: October 17, 2014 at 7:29 am ESTBy: Hannah Ishmael
Click Ticker to See live coverage

IBIO
SRPT
NLNK
BCRX
APT

Ibio Inc (IBIO) traded up 15% during extended trading yesterday following the announcement that it had offered its proprietary antibody technology, iBioLaunch, to the US government to help fight the Ebola outbreak.

The technology is meant for emergency use to optimize the manufacturing process of certain experimental antibody-based drugs that are being given to Ebola victims.

Yesterday’s announcement was the company’s response to shareholders and media’s questions regarding its contribution toward controlling the spread of the virus in the US, Europe, and West Africa.

Ibio stock was up 36% during trading yesterday, and about 30 million shares were traded, compared to a 30-day average trading volume of only 2.8 million shares.
Ibio And Caliber Biotherapeutics

Ibio also highlighted its licensing and collaboration agreement with Caliber Biotherapeutics in a press release. Both companies have been working together since February last year to exploit commercial opportunities to produce “recombinant antibodies” and antibody-related proteins.

Caliber Biotherapeutics has the world’s largest facility to produce drugs from tobacco plants. Ibio’s iBioLaunch technology, on the other hand, is capable of producing pharmaceutical proteins in plants with speed and efficiency, along with providing greater cost advantages over bioreactor-based manufacturing systems.
The Trio: Ibio, Caliber Biotherapeutics, And Mapp Biopharmaceutical

Mapp Biopharmaceutical has developed a drug called ZMapp, which has proven to be effective in treating the Ebola virus that has killed about 4,000 people so far. The drug is manufactured using tobacco plants, and has been administered to two Ebola-afflicted Americans, a Spanish priest, and three Liberian health workers. It is one of the most advanced anti-Ebola drugs to have been produced so far. Its supply, however, has been exhausted.

Caliber Biotherapeutics’ facility can be used to produce 25 to 75 kilograms of ZMapp per annum, according to estimates reported by Bloomberg. It is difficult to manufacture the drug in large quantities because it is a cocktail of three antibodies, which requires triple the amount of tobacco plants as compared to normal drugs. The dosage of ZMapp demanded by victims is also higher compared to other drugs, which further necessitates higher supply of the drug.

Investors are expecting iBioLaunch technology to speed up ZMapp’s production, which is the primary reason behind the surge of about 174% in Ibio stock over the past one month.

Page 1 of 2

I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vermiculus Unveils VeriIndex: A Game-Changer for Indices

Updated Category News Views 5

Standing on the Precipice of Index Innovation There’s a seismic shift rumbling through Vermiculus as they roll out their latest brainchild, the VeriIndex. This isn’t just your typical release; it’s the kind of shakeup that slaps you awake like a splash of cold water. Ever since they burst onto the scene in 2020, Vermiculus has been stirring the pot of exchange...

Continue Reading
American Lung Association Tackles Indoor Pollution

Updated Category News Views 6

The Unseen Threat Lurking Indoors When you think about air pollution, your mind probably jumps to smog-choked city streets. But, surprise! The air inside your cozy living room could actually be pulling a fast one on you, being two to five times filthier than what’s outside. Now, that’s a hair-raising thought. A Closer Look at Indoor Air Hazards Folks don’t usually...

Continue Reading
VIAVI's 37% NetSecOps Uptick: A Mixed Bag for Firms

Updated Category News Views 5

Networking and Security: The Clash of the Titans The IT world sure loves mixing and matching its acronyms these days, doesn’t it? VIAVI Solutions, an ace in hybrid network-security operations, just released their 18th annual 'State of the Network' study. Tipping the hat to progress, they've reported a 37% jump in firms that have embraced NetSecOps over the past year....

Continue Reading
Moises and SoundCloud Join Forces to Empower Musicians

Updated Category News Views 5

Paving the Way for Artist Empowerment You ever wake up and feel like the music world just shifted? Like the landscape just got smoother for artists trying to juggle creativity and business without losing their minds? Well, Moises and SoundCloud teaming up might be just that seismic shift. Playing in the Big Leagues with Moises' Creative Suite Let's not fool...

Continue Reading
Greenland Energy Board Reshuffle: McIllree Exits

Updated Category News Views 5

A Change in Greenland Energy's Lineup Well, folks, the wheel keeps turning at Greenland Energy Company (NASDAQ:GLND). Roderick McIllree has decided to step off the Board of Directors' carousel, effective immediately. And nope, there wasn't a classic showdown or any disagreement on the table. This exit is as drama-free as they come—just him stepping aside, leaving the...

Continue Reading
European Flavors: A Halloween Food Revolution

Updated Category News Views 6

Who would've thought Halloween would toss a spin on fine dining? What's usually known for candy corn and spooky costumes has teamed up with European flavors for a night unlike any other. And we're talking more than just trick-or-treating here, folks. A New Kind of Halloween Spread This year, The Charming Taste of Europe has thrown itself into the Halloween festivities,...

Continue Reading
Coles Teams Up with Coveo to Boost Online Grocery Shopping

Updated Category News Views 3

Coles and Coveo: A Tech Partnership Worth Watching Buckle up, folks, because Coles Group Limited has chosen Coveo, the hotshot in AI-relevance, to revamp the online shopping landscape for its grocery business. Let's break down why this matters for both the grocery shopper hustling between work and carbs and the savvy investor eyeing the digital retail frontier. Enhancing...

Continue Reading
School Safety: Revamping Response Coordination

Updated Category News Views 5

Revamp in Emergency Training for School Incidents No longer can schools afford the luxury of uncoordinated chaos during emergencies. Today, the firepower behind the National Center for Integrated Emergency Response (NCIER) comes from the realization that courage alone doesn't cut it. It's about time someone put the pieces together, getting cops, fire, school staff, and...

Continue Reading
Top Seedz: Seeds Drive Growth in Crowded Cracker Market

Updated Category News Views 2

Breaking the Cracker Mold with Seeds Ever thought crackers could be more than just a canvas for cheese? Well, Top Seedz out of Buffalo is redefining the snack aisle with its seed-centric approach. In a whopping $25 billion global cracker market, this woman-owned outfit is carving out its niche by flipping conventional recipes on their heads. They're not just tossing seeds...

Continue Reading
Duolingo Faces Class Action: Investors Brace for Impact

Updated Category News Views 3

Going Beyond Language Learning Hype Listen, it's not every day you wake up to a lawsuit calling out one of those seemingly indestructible tech darlings. Well, Duolingo (NASDAQ: DUOL) is caught in the crosshairs now. They face allegations of pulling the wool over investors' eyes about their monetization and growth tactics. If you snapped up some stock between May 2, 2025,...

Continue Reading

Top 5 Most Recently Viewed Articles

FastPassCorp Reports Strong Equity Recovery and Order Growth

Updated Category News Views 150

FastPassCorp Reports Strong Equity Recovery and Growth Opportunities In a recent announcement, FastPassCorp A/S highlighted notable developments in its financial performance and market presence. The company has successfully recovered its equity, with significant improvements reported in its recent financial results. This positive trend not only reflects the company's...

Continue Reading
Brera Holdings Strengthens Community Bonds Through Juve Stabia

Updated Category News Views 244

Building Strong Community Ties with Juve Stabia Brera Holdings PLC, an international holding company, is making strides in enhancing its connection with S.S. Juve Stabia Srl, poised to be a powerful partnership focused on community development. The recent meeting involving Brera Holdings' Executive Chairman, Daniel McClory, with local officials underscores a commitment to...

Continue Reading
Market Update: Futures Decline as Nvidia's Outlook Dims

Updated Category News Views 240

Market Overview European and US equity futures have dipped following Nvidia Corp.'s disappointing outlook, which has dampened the momentum of the global AI rally. Contracts for the Euro Stoxx 50 fell by 0.2%, while futures on the Nasdaq 100 Index decreased by 0.5%. In Asia, a benchmark index also slipped by 0.2%, significantly influenced by chipmakers like Taiwan...

Continue Reading
Aldebaran Resources Advances Joint Venture with Nuton Holdings

Updated Category News Views 142

Aldebaran Resources Moves Forward with Nuton Holdings Aldebaran Resources Inc. is making strides in its partnership with Nuton Holdings Ltd., which is a joint venture with Rio Tinto. Recently, it was confirmed that Nuton will proceed with its second payment of USD 20 million as part of their Option to Joint Venture Agreement regarding the Altar project. Understanding the...

Continue Reading
Rhythm Pharmaceuticals Plans $150 Million Stock Offering to Fund Growth

Updated Category News Views 176

Rhythm Pharmaceuticals Unveils New Stock Offering Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a dedicated biopharmaceutical company focused on improving the lives of patients with rare neuroendocrine diseases, is excited to announce its proposed public offering of $150 million of common stock. This offering is designed to bolster the company’s growth and innovation in...

Continue Reading